BNC2-AS1

Across TCGA pan-cancer cohorts, BNC2-AS1 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated BNC2-AS1 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher BNC2-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BNC2-AS1 expression acts as an unfavorable survival marker, although some lineages such as CESC and CHOL show a favorable association.

UCEC, KIRC, and CESC are the cancer types where BNC2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	All	0.608	0.727	<.001	54	view →
KIRC	DFS	Median	All	0.834	0.907	.004	50	view →
CESC	DFS	Median	IV	0.528	0.085	.002	30	view →
HNSC	OS	Median	All	0.263	0.504	<.001	29	view →
LUAD	DFS	Median	IV	0.276	0.729	.011	24	view →
THCA	OS	Tertile	III,IV	0.934	1.000	.010	21	view →
GBM	OS	Median	All	0.319	0.498	<.001	18	view →
CHOL	DFS	Median	II,III,IV	0.588	0.104	.008	14	view →
OV	OS	Quartile	All	0.912	0.808	.003	12	view →
DLBC	OS	Median	IV	1.000	0.417	.013	12	view →
ESCA	DFS	Median	III,IV	0.436	0.228	.006	11	view →
LGG	DFS	Median	All	0.845	0.662	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

BNC2-AS1–UCEC (OS)

Open the UCEC breakdown →